Ireland vs Tanzania, United Republic of: Access to anti-retroviral drugs, female
Ireland
90.0%
in 2023
Tanzania, United Republic of
90.0%
in 2024
Ireland rank
27th
Tanzania, United Republic of rank
27th
Access to anti-retroviral drugs, female over time
- Ireland
- Tanzania, United Republic of
How they compare
Ireland currently reports 90.0% against 90.0% in Tanzania, United Republic of, a difference of 0.0%.
Across all 24 years both countries report, Ireland has been ahead every year.
Ireland ranks 27th and Tanzania, United Republic of ranks 27th of 141 countries.
Ireland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ireland | Tanzania, United Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.1% | 4.7% | 58.4% | Ireland |
| 2010s | 76.3% | 44.5% | 31.8% | Ireland |
| 2020s | 88.8% | 75.0% | 13.8% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Ireland or Tanzania, United Republic of?
- Ireland, at 90.0% against 90.0% in Tanzania, United Republic of as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Ireland and Tanzania, United Republic of?
- 0.0%, with Ireland ahead.
- How many years of comparable data are there for Ireland and Tanzania, United Republic of?
- 24 years are reported by both, from 2000 to 2023.
- How do Ireland and Tanzania, United Republic of rank globally for access to anti-retroviral drugs, female?
- Ireland ranks 27th and Tanzania, United Republic of ranks 27th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.